Clinical Newsletter

Clinical Newsletter

Regular updates on our latest clinical studies.

Subscribe

Búsqueda de publicación

Nuestros equipos de investigación y desarrollo operan a nivel global y generan sinergias desde nuestra experiencia colectiva y a partir de disciplinas relacionadas. Del mismo modo estamos intercambiando información constantemente a nivel internacional con instituciones técnicas independientes, importantes líderes y multiplicadores de opinión para poder garantizar una gestión de la cooperación y del conocimiento al más alto nivel. Como parte de este proceso, también llevamos a cabo una investigación exhaustiva, cuyos resultados presentamos continuamente en workshops, conferencias y simposios - tanto en forma de documentación gratuita, como en ponencias ofrecidas por nuestros socios cooperadores - así como publicaciones en prensa científica de renombre. Esta base de datos contiene un largo número de estos artículos basados en evidencias científicas, cuya mayoría ha sido evaluada por asesores independientes:

  1. Journal article

    Reimbursement of Compression Therapy Europe - An Overview

    Journal of wound technology 2010 62 65
  2. Journal article

    Formulation and stability of a novel artificial sebum under conditions of storage and use

    International journal of cosmetic science 2010 32 (5) 347 355

    Materials in contact with liquids on the human skin surface may dissolve and permeate into skin. Release and permeation of chemicals in contact with skin is often estimated in vitro using artificial skin liquids, although sebum lipids are generally not included in these models. The purposes of this research were to develop a representative artificial sebum that contains the appropriate types of lipids at levels that match human values and quantitatively characterize the model to understand its utility for in vitro testing. Artificial sebum that consisted of 10 lipids at proportions that closely resembled human sebum was characterized using thin layer chromatography under a variety of storage and use conditions (dry and liquid, 4 degrees C and 32 degrees C, with and without vitamin E) for 28 days. Levels of sebum constituents maintained in solution and dry at 4 degrees C were stable through the duration of the test period. Levels of all sebum lipids maintained dry at 32 degrees C were stable in the presence of vitamin E; however, squalene oxidized rapidly in the absence of vitamin E. Liquids on the human skin surface consist of sebum and sweat with minor amounts of cellular debris and intercellular lipid from the stratum corneum. The relative importance of each component for release of chemicals from materials in contact with skin will depend upon the type of material (metal, organic, etc.). A model artificial sebum was formulated and characterized to aid researchers in understanding potential release of chemicals from materials in contact with skin and subsequent partitioning and absorption.

    PMID 20491993
  3. Journal article

    Protease and pro-inflammatory cytokine concentrations are elevated in chronic compared to acute wounds and can be modulated by collagen type I in vitro

    Archives of dermatological research 2010 302 (6) 419 428

    Physiological wound repair is a highly regulated, complex process, which leads to formation of new tissue after injury. However, the healing process is not perfect and healing impairments can occur. Delayed healing and formation of chronic wounds has been linked to the excessive production of proteolytic enzymes leading to reduced amounts of growth factors and successive destruction of the extracellular matrix. It has been implied that there is an alteration in the normal control mechanisms regulating the levels of these enzymes. The study presented provides data on the concentration of proteases and cytokines in wound fluid from chronic when compared with acute wounds. Levels of proteases such as PMN elastase, matrix metalloproteinases-2 (MMP-2), and MMP-13 were found to be profoundly elevated in chronic when compared with acute wound fluids. In addition, concentrations of IL-1beta, IL-6, and IL-8 were shown to be significantly higher in chronic than in acute wounds. Furthermore, the ability of a wound dressing, consisting of bovine collagen type I, to bind pro-inflammatory cytokines was investigated. Collagen type I was able to bind significant amounts of the pro-inflammatory cytokines in vitro. Thus, it should be able to establish a more physiological wound milieu in vivo and promote healing.

    PMID 20033193
  4. Poster

    The management and treatment of an MRSA leg ulcer in a Raynaud’s patient

    Poster presented at Wounds UK 2009 09.11.2009 Harrogate, UK
  5. Poster

    The role of the Tissue Viability Nurse in the management of diabetic foot ulceration

    Poster presented at Wounds UK 2009 09.11.2009 Harrogate, UK
  6. Poster

    Treatment of a skin flap laceration with Suprasorb® X+PHMB

    Poster presented At Wounds UK 2009 09.11.2009 Harrogate, UK
  7. Poster

    The use of Suprasorb® X+PHMB on a recurring leg ulcer

    Poster presented at Wounds UK 2009 09.11.2009 Harrogate, UK
  8. Poster

    No resistance after 100 days repeated incubation of Staphylococcus aureuswith polihexanide

    Poster presented at Wounds UK 2009 09.11.2009 Harrogate, UK
  9. Poster

    Superabsorbent wound dressings in clinical practice - Problem solving in heavy exuding wounds

    Poster presented at Wounds UK 2009 09.11.2009 Harrogate, UK
    Products Vliwazell , Vliwasorb
    Further languages
  10. Poster

    The management of maceration in a Nursing Home environment

    Poster presented at Wounds UK 2009 09.11.2009 Harrogate, UK

Aviso COFEPRIS 183300202C1039

Este sitio web contiene información sobre productos y prácticas médicas, está dirigido a una amplia audiencia y podría contener datos de productos o información que no son accesibles o válidos en su país. Tenga en cuenta que nosotros no tomamos ninguna responsabilidad por acceder a información que puede que no cumpla con algún requerimiento legal, de regulación, de registro o de uso en su país de origen. Las prácticas y regulaciones médicas pueden diferir de un país a otro.